• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素香料给药对肠道微生物群的调节作用及其药理学意义。

Regulative effects of curcumin spice administration on gut microbiota and its pharmacological implications.

作者信息

Shen Liang, Liu Lu, Ji Hong-Fang

机构信息

Shandong Provincial Research Center for Bioinformatic Engineering and Technique, School of Life Sciences, Shandong University of Technology, Zibo, PR China.

出版信息

Food Nutr Res. 2017 Aug 9;61(1):1361780. doi: 10.1080/16546628.2017.1361780. eCollection 2017.

DOI:10.1080/16546628.2017.1361780
PMID:28814952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5553098/
Abstract

Curcumin, the major active component of turmeric (), is widely used as a spice and food-coloring agent, and also exhibits multiple biological activities. However, as curcumin has poor systemic bioavailability its pharmacology remains to be elucidated. Owing to the high concentration of curcumin in the gastrointestinal tract after oral administration, we hypothesize that it may exert regulative effects on the gut microbiota. We investigated the regulative effects of oral curcumin administration on the gut microbiota of C57BL/6 mice and found that curcumin significantly affected the abundance of several representative families in gut microbial communities, including Prevotellaceae, Bacteroidaceae, and Rikenellaceae. Considering the pathogenic associations between gut microbiota and many diseases, the present findings may help us to interpret the therapeutic benefits of curcumin.

摘要

姜黄素是姜黄的主要活性成分,被广泛用作香料和食品着色剂,还具有多种生物活性。然而,由于姜黄素的全身生物利用度较差,其药理学机制仍有待阐明。口服给药后,胃肠道中姜黄素浓度较高,因此我们推测它可能对肠道微生物群产生调节作用。我们研究了口服姜黄素对C57BL/6小鼠肠道微生物群的调节作用,发现姜黄素显著影响肠道微生物群落中几个代表性菌科的丰度,包括普雷沃氏菌科、拟杆菌科和理研菌科。鉴于肠道微生物群与许多疾病之间的致病关系,目前的研究结果可能有助于我们理解姜黄素的治疗益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b08f/5553098/b14fc9a7b9f7/zfnr_a_1361780_f0002_c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b08f/5553098/ea5680bea5ac/zfnr_a_1361780_f0001_c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b08f/5553098/b14fc9a7b9f7/zfnr_a_1361780_f0002_c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b08f/5553098/ea5680bea5ac/zfnr_a_1361780_f0001_c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b08f/5553098/b14fc9a7b9f7/zfnr_a_1361780_f0002_c.jpg

相似文献

1
Regulative effects of curcumin spice administration on gut microbiota and its pharmacological implications.姜黄素香料给药对肠道微生物群的调节作用及其药理学意义。
Food Nutr Res. 2017 Aug 9;61(1):1361780. doi: 10.1080/16546628.2017.1361780. eCollection 2017.
2
Interaction between Gut Microbiota and Curcumin: A New Key of Understanding for the Health Effects of Curcumin.肠道微生物群与姜黄素的相互作用:理解姜黄素健康效应的新关键。
Nutrients. 2020 Aug 19;12(9):2499. doi: 10.3390/nu12092499.
3
Bidirectional interactions between dietary curcumin and gut microbiota.膳食姜黄素与肠道微生物群的双向相互作用。
Crit Rev Food Sci Nutr. 2019;59(18):2896-2902. doi: 10.1080/10408398.2018.1478388. Epub 2018 Dec 30.
4
Gut Microbiota as a Prospective Therapeutic Target for Curcumin: A Review of Mutual Influence.姜黄素的潜在治疗靶点——肠道微生物群:相互影响的综述
J Nutr Metab. 2018 Dec 16;2018:1367984. doi: 10.1155/2018/1367984. eCollection 2018.
5
Bidirectional interactions between curcumin and gut microbiota in transgenic mice with Alzheimer's disease.阿尔茨海默病转基因小鼠中姜黄素与肠道微生物群的双向相互作用。
Appl Microbiol Biotechnol. 2020 Apr;104(8):3507-3515. doi: 10.1007/s00253-020-10461-x. Epub 2020 Feb 24.
6
Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review.姜黄(姜黄属植物)及其主要成分(姜黄素)作为无毒和安全的物质:综述。
Phytother Res. 2018 Jun;32(6):985-995. doi: 10.1002/ptr.6054. Epub 2018 Feb 26.
7
Curcumin, Gut Microbiota, and Neuroprotection.姜黄素、肠道微生物群与神经保护。
Nutrients. 2019 Oct 11;11(10):2426. doi: 10.3390/nu11102426.
8
Effects of Turmeric and Curcumin Dietary Supplementation on Human Gut Microbiota: A Double-Blind, Randomized, Placebo-Controlled Pilot Study.姜黄和姜黄素膳食补充剂对人体肠道微生物群的影响:一项双盲、随机、安慰剂对照的初步研究。
J Evid Based Integr Med. 2018 Jan-Dec;23:2515690X18790725. doi: 10.1177/2515690X18790725.
9
Is boiled food spice curcumin still biologically active? An experimental exploration.煮熟的食品香料姜黄素仍具有生物活性吗?一项实验探索。
Food Nutr Res. 2018 Jun 20;62. doi: 10.29219/fnr.v62.1397. eCollection 2018.
10
NTP Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).姜黄油树脂(化学物质登记号:8024-37-1)(主要成分79%-85%为姜黄素,化学物质登记号:458-37-7)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学与致癌性研究(饲料喂养研究)
Natl Toxicol Program Tech Rep Ser. 1993 Aug;427:1-275.

引用本文的文献

1
Role of curcumin in altering gut microbiota for anti-obesity and anti-hyperlipidemic effects.姜黄素在改变肠道微生物群以产生抗肥胖和抗高血脂作用中的作用。
Front Microbiol. 2025 Aug 20;16:1625098. doi: 10.3389/fmicb.2025.1625098. eCollection 2025.
2
The role of nutrition and gut microbiome in childhood brain development and behavior.营养与肠道微生物群在儿童大脑发育和行为中的作用。
Front Nutr. 2025 Jun 9;12:1590172. doi: 10.3389/fnut.2025.1590172. eCollection 2025.
3
Curcumin Modulation of the Gut-Brain Axis for Neuroinflammation and Metabolic Disorders Prevention and Treatment.

本文引用的文献

1
Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats.姜黄素介导的肠道微生物群调节可减轻大鼠肝脂肪变性。
Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1801-1812. doi: 10.1016/j.bbagen.2017.03.017. Epub 2017 Mar 21.
2
The gut microbiota and metabolic disease: current understanding and future perspectives.肠道微生物群与代谢疾病:当前的认识和未来展望。
J Intern Med. 2016 Oct;280(4):339-49. doi: 10.1111/joim.12508. Epub 2016 Apr 12.
3
Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel disease.
姜黄素对肠-脑轴的调节作用,用于预防和治疗神经炎症及代谢紊乱
Nutrients. 2025 Apr 24;17(9):1430. doi: 10.3390/nu17091430.
4
Overview of pharmacodynamical research of traditional Chinese medicine on hyperuricemic nephropathy: from the perspective of dual-regulatory effect on the intestines and kidneys.基于对肠道和肾脏双重调节作用视角的中药对高尿酸血症肾病药效学研究概述
Front Pharmacol. 2025 Apr 8;16:1517047. doi: 10.3389/fphar.2025.1517047. eCollection 2025.
5
The gut-heart axis: a review of gut microbiota, dysbiosis, and cardiovascular disease development.肠道-心脏轴:肠道微生物群、生态失调与心血管疾病发展综述
Ann Med Surg (Lond). 2025 Jan 9;87(1):177-191. doi: 10.1097/MS9.0000000000002789. eCollection 2025 Jan.
6
Biocompatible Poly(ε-Caprolactone) Nanocapsules Enhance the Bioavailability, Antibacterial, and Immunomodulatory Activities of Curcumin.生物相容的聚己内酯纳米胶囊提高姜黄素的生物利用度、抗菌和免疫调节活性。
Int J Mol Sci. 2024 Oct 4;25(19):10692. doi: 10.3390/ijms251910692.
7
Nutrition Intervention and Microbiome Modulation in the Management of Breast Cancer.营养干预与微生物组调节在乳腺癌管理中的作用。
Nutrients. 2024 Aug 10;16(16):2644. doi: 10.3390/nu16162644.
8
Dietary Polyphenols and Gut Microbiota Cross-Talk: Molecular and Therapeutic Perspectives for Cardiometabolic Disease: A Narrative Review.饮食多酚与肠道微生物群相互作用:心脏代谢疾病的分子和治疗观点:叙述性评论。
Int J Mol Sci. 2024 Aug 22;25(16):9118. doi: 10.3390/ijms25169118.
9
Curcumin and Gut Microbiota: A Narrative Overview with Focus on Glycemic Control.姜黄素与肠道微生物群:以血糖控制为重点的叙述性综述。
Int J Mol Sci. 2024 Jul 14;25(14):7710. doi: 10.3390/ijms25147710.
10
Gut-Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on α-Synuclein in Parkinson's Disease.聚焦肠脑轴:多酚、微生物群及其对帕金森病中α-突触核蛋白的影响。
Nutrients. 2024 Jun 27;16(13):2041. doi: 10.3390/nu16132041.
姜黄素作为炎症性肠病化学预防的治疗剂。
Drug Discov Today. 2016 May;21(5):843-9. doi: 10.1016/j.drudis.2016.03.007. Epub 2016 Mar 16.
4
How does curcumin work with poor bioavailability? Clues from experimental and theoretical studies.姜黄素生物利用度差时如何发挥作用?来自实验和理论研究的线索。
Sci Rep. 2016 Feb 18;6:20872. doi: 10.1038/srep20872.
5
Intestinal Microbiota and Metabolic Diseases: Pharmacological Implications.肠道微生物群与代谢疾病:药理学意义。
Trends Pharmacol Sci. 2016 Mar;37(3):169-171. doi: 10.1016/j.tips.2015.11.010. Epub 2015 Dec 17.
6
Alterations of the human gut microbiome in liver cirrhosis.肝硬化患者的肠道微生物组变化。
Nature. 2014 Sep 4;513(7516):59-64. doi: 10.1038/nature13568. Epub 2014 Jul 23.
7
Can improving bioavailability improve the bioactivity of curcumin?提高生物利用度能否提高姜黄素的生物活性?
Trends Pharmacol Sci. 2014 Jun;35(6):265-6. doi: 10.1016/j.tips.2014.04.001. Epub 2014 Apr 23.
8
The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer.姜黄素及其代谢物在癌症方面的药代动力学和药效学的分子基础。
Pharmacol Rev. 2013 Dec 24;66(1):222-307. doi: 10.1124/pr.110.004044. Print 2014.
9
Gut microbiota from twins discordant for obesity modulate metabolism in mice.肥胖症双胞胎的肠道微生物群可调节小鼠的代谢。
Science. 2013 Sep 6;341(6150):1241214. doi: 10.1126/science.1241214.
10
Dietary intervention impact on gut microbial gene richness.饮食干预对肠道微生物基因丰富度的影响。
Nature. 2013 Aug 29;500(7464):585-8. doi: 10.1038/nature12480.